Trade Ideas November 20, 2026 10:55 PM

Radian's Diversified Insurance Mix Looks Cheap — Long on Value and Optionality

Underappreciated specialty insurance gains and strong cash flow make RDN a tactical long for the next earnings cycle

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
RDN

Radian Group (RDN) is trading at a depressed multiple despite improving specialty insurance fundamentals, steady cash generation and a low leverage profile. The market appears to underweight the earnings accretion from the Inigo acquisition and the company's shift toward higher-return lines. We lay out an actionable long trade for a mid-term horizon with defined entry, stop and target, and a balanced risk framework.

Radian's Diversified Insurance Mix Looks Cheap — Long on Value and Optionality
RDN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Radian trades near $36.86 with a P/E around 8.9x and P/B near 1.02x — attractive on headline multiples.
  • Free cash flow of ~$1.39B against a ~$4.66B market cap implies a very high FCF yield and capital return optionality.
  • Specialty Insurance posted an improved combined ratio (80.4%) in Q3 2026 and revenue jumped ~106% YoY driven by the Inigo acquisition.
  • Actionable trade: Long entry $36.50, stop $33.50, target $41.00, mid-term horizon (45 trading days).

Hook & thesis

Radian Group (RDN) is a simple valuation story with an execution kicker. The stock currently trades near $36.86 and carries single-digit P/E and near-par price-to-book multiples, yet the market has not fully priced in the higher-margin specialty insurance earnings and a large free cash flow stream. For investors who want a fundamentally defensible play on mortgage-related risk transfer and specialty insurance growth, RDN looks compelling as a mid-term swing trade.

We think the market is underestimating two things: first, the earnings leverage from Radian's move into specialty products (Inigo acquisition) that boosted Q3 operating results; and second, the capital return optionality from a business that produces meaningful free cash flow while keeping leverage light. That combination argues for a re-rating toward peers over the next several weeks to months.

What Radian does and why it matters

Radian Group is a holding company focused on mortgage insurance, mortgage credit risk transfer and real estate services. The core mortgage insurance business aggregates and distributes U.S. mortgage credit risk for lenders and investors; the specialty insurance businesses expand the company's exposure into higher-return, policy-based underwriting. For capital allocators this is attractive because mortgage insurance creates recurring fee-like economics while specialty underwriting can expand margins and returns on equity.

Why the market should care now

Three fundamental drivers make RDN worth a fresh look.

  • Improving specialty performance: Q3 2026 adjusted operating income came in at $1.44 per share, a 13% beat vs consensus, with Specialty Insurance delivering an improved combined ratio of 80.4% per the company's disclosures on 11/05/2026. That is a material improvement and points to sustainable profitability in the higher-margin mix.
  • Material free cash flow: The firm reported free cash flow of roughly $1.39 billion at its most recent ratios snapshot. Against a market cap of about $4.66 billion, that's a striking FCF yield and gives the company optionality to buy back shares, pay dividends and/or de-lever selectively.
  • Low leverage and solid returns: Radian runs conservative balance sheet metrics — debt-to-equity near 0.26 and return on equity roughly 11.15% — giving it room to deploy capital without stretching risk appetite.

Support from the numbers

Key metrics from the snapshot:

Metric Value
Current price $36.86
Market cap $4.66B
P/E ~8.9x
P/B ~1.02x
Free cash flow (trailing) $1.39B
Dividend (quarterly) $0.255 per share (ex-dividend 11/23/2026)
Return on equity ~11.15%
Debt / Equity ~0.26

Those numbers make it hard to argue that Radian is expensive: earnings are available at single-digit multiples, and capital returns are bolstered by strong FCF. The recent quarter (reported 11/05/2026 and 11/04/2026) showed specialty insurance strength and revenue upside from the Inigo acquisition (revenues jumped ~106% year-over-year to ~$624M in one publication and ~$628M in another), which suggests the composition of earnings is improving.

Valuation framing

At a market cap of ~$4.66B and enterprise value near $5.72B, Radian trades at EV/EBITDA of ~7.1x and a P/E in the high single digits. On a free cash flow basis the company generates roughly $1.39B, implying an FCF yield near 30% against market cap. Those are headline numbers — you should normalize for the mortgage cycle — but even after conservative adjustments, the company looks cheap for a financial services firm with improving specialty margins and modest leverage.

Price-to-book around 1.02x suggests limited downside to tangible book-value perceptions. If specialty underwriting continues to post combined ratios in the low 80s and mortgage defaults stabilize, a multiple re-rating toward low-teens P/E or modest expansion in price-to-book seems reasonable, which underpins our upside target below.

Catalysts (2-5)

  • Integration and earnings accretion from the Inigo acquisition, which already showed up in Q3 numbers on 11/05/2026.
  • Upcoming quarterly reporting cadence and analyst revisions. A second consecutive beat in specialty profitability would force analysts to raise estimates.
  • Capital deployment decisions: continued buybacks or a raised dividend, funded by the substantial free cash flow, would be a tangible re-rating trigger.
  • Macro stabilization in mortgage delinquencies and home price trends would reduce uncertainty around the mortgage segment and shrink the discount applied by the market.

Technical and market structure notes

Technically, RDN sits above several short-term moving averages: 10-day SMA ~$36.74, 20-day SMA ~$36.34 and 50-day SMA ~$34.89, with an RSI around 57 — not overbought but showing constructive tone. MACD shows slightly bearish momentum, and short interest has been meaningful at different settlement points (days to cover ranging from ~3.7 to ~5.7 historically), which implies a non-trivial short base that could exacerbate upside on positive news.

Trade plan (actionable)

Direction: Long RDN

Entry price: 36.50

Stop loss: 33.50

Target price: 41.00

Time horizon: mid term (45 trading days). Rationale: the trade intends to capture an earnings/re-rating cycle and near-term execution on specialty insurance integration and capital deployment decisions. Forty-five trading days covers the next company commentary windows and allows the market time to re-evaluate multiples.

Plan mechanics: Enter at $36.50 (limit). Initial position size should reflect the stop at $33.50 — a roughly $3.00 risk per share — and risk tolerance. Move the stop to breakeven once the trade is +$1.50, and consider trimming into strength above $39.00 as option value and sentiment shift become evident. Target $41.00 reflects reclaiming toward the 52-week high ($41.05 on 07/14/2026) while still leaving room for upside if specialty momentum compounds.

Risks and counterarguments

  • Mortgage credit deterioration: If defaults and loss severities accelerate materially, the mortgage insurance franchise could reintroduce volatility to earnings and reserves, pressuring the stock below the stop. Mortgage exposure is the firm's core business.
  • Specialty underwriting shock: Specialty insurance can swing quickly with large losses or reserve development. A single loss-heavy period could erase near-term profitability gains.
  • Market multiple compression: Financials can trade lower on macro shocks or higher rates of reserve discounting; even healthy firms see multiple compression in risk-off periods.
  • Execution on capital allocation: If management chooses to consume cash with sub-accretive deals instead of buybacks/dividends, investor sentiment could sour and delay re-rating.
  • Short-interest and volatility: A significant short base can produce outsized moves in both directions; positive news could spark a squeeze but negative headlines could create exaggerated downside pressure.

Counterargument: The stock is cheap for a reason — the mortgage cycle remains an unknown and the company's mortgage insurance book could see reserve volatility that makes the high FCF look ephemeral. If macro credit trends deteriorate more rapidly than the market expects, the valuation gap can widen further and our thesis would fail.

What would change my mind

I remain constructive provided specialty combined ratios remain sub-90 and free cash flow stays near the current run-rate. I would change my view if any of the following occur:

  • Q4 or subsequent quarters show deteriorating specialty combined ratios back to the mid-90s or worse.
  • Management pivots to heavy, overpriced M&A instead of returning cash to shareholders.
  • Mortgage default metrics accelerate materially and force large reserve builds that crush reported earnings and tangible book value.

Conclusion

Radian offers a straightforward risk/reward setup: a near-term entry at $36.50, a conservative stop at $33.50 and a $41.00 target that represents a modest multiple and valuation normalization toward prior highs. With strong free cash flow ($1.39B), low leverage (debt/equity ~0.26) and improving specialty profitability, the equity looks undervalued relative to its earnings power. The trade is best sized as a mid-term swing (45 trading days) to capture re-rating and execution outcomes. Monitor specialty combined ratios and mortgage credit trends closely; those two indicators will drive whether RDN earns a higher multiple or reverts lower.

Risks

  • Mortgage credit deterioration that forces significant reserve builds and damages earnings and book value.
  • Adverse loss development or a large single-event in the specialty insurance book that reverses margin gains.
  • Management uses free cash flow for overpriced M&A instead of shareholder returns, delaying re-rating.
  • Market multiple compression for financials in a broad risk-off environment, regardless of company fundamentals.

More from Trade Ideas

AST SpaceMobile: Operational Setbacks Create a Mid‑Term Long Trade — Delays, Not Doom Nov 21, 2026 Anthropic: A Practical Long on Monetization Signals — Trade Plan Inside Nov 21, 2026 Lumentum: Deep Pullback, Tactical Upside — Upgrading to Strong Buy Nov 21, 2026 Zimmer Biomet: Buy on Cash Flow Strength and Durable Orthopedics Demand Nov 21, 2026 Ladder Capital: Buy for the Yield and a Better-Than-Peer Balance Sheet Nov 21, 2026